WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (NASDAQ:NURO) today announced that the company, in
partnership with Advantage Healthcare, will explore Quell® retail
expansion plans with executives from key national and regional drug
chains and mass merchandisers at the NCADS Total Store Expo taking place
in Boston from August 6 to 9.
"NACDS Total Store Expo is the drug store industry's largest annual
meeting," says Clark Brown, Chief Operating Officer of Advantage
Healthcare. "We are looking forward to working with NeuroMetrix to
further expand Quell distribution and make it available to consumers
through retailers across the US."
About Quell Wearable Pain Relief Technology
Quell is FDA cleared and designed for the millions of people suffering
from chronic pain. The advanced wearable technology delivers 100% drug
free relief and is available without a prescription. Quell can be used
during the day while active, and at night while sleeping. Quell gives
users the option to start, stop, and adjust therapy discreetly via their
smartphone. It also provides therapy utilization and advanced sleep
tracking. Quell is available at select healthcare professionals and
retailers. To find a Quell retailer, visit the Store
Locator at QuellRelief.com.
About Advantage Consumer Healthcare
Advantage Consumer Healthcare is a full-service, sales, marketing and
supply chain company that manages over 45 Brands representing over $2
Billion in retail sales. The ACH team average 25 years of experience and
have worked in senior roles with some of the best healthcare companies
in the world, and has a successful track record helping to create new
categories in the OTC healthcare space including Lip Care, Smoking
Control & Weight Control.
About NeuroMetrix
NeuroMetrix is an innovative healthcare company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160803005947/en/
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
